Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas.

Cannavo S, Ferrau F, Cotta OR, Saitta S, Barresi V, Cristani MT, Saija A, Ruggeri RM, Trimarchi F, Gangemi S.

Pituitary. 2014 Feb;17(1):76-80. doi: 10.1007/s11102-013-0468-2.

PMID:
23512698
[PubMed - indexed for MEDLINE]
2.

Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide.

Colao A, Ferone D, Lastoria S, Cerbone G, Di Sarno A, Di Somma C, Lucci R, Lombardi G.

Clin Endocrinol (Oxf). 2000 Apr;52(4):437-45.

PMID:
10762286
[PubMed - indexed for MEDLINE]
3.

Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.

Karavitaki N, Thanabalasingham G, Shore HC, Trifanescu R, Ansorge O, Meston N, Turner HE, Wass JA.

Clin Endocrinol (Oxf). 2006 Oct;65(4):524-9.

PMID:
16984247
[PubMed - indexed for MEDLINE]
4.

In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand.

de Herder WW, Reijs AE, Kwekkeboom DJ, Hofland LJ, Nobels FR, Oei HY, Krenning EP, Lamberts SW.

Clin Endocrinol (Oxf). 1996 Dec;45(6):755-67.

PMID:
9039343
[PubMed - indexed for MEDLINE]
5.

Effectiveness of a long-acting injectable form of bromocriptine in patients with prolactin and growth hormone secreting macroadenomas.

Tsagarakis S, Tsiganou E, Tzavara I, Nikolou H, Thalassinos N.

Clin Endocrinol (Oxf). 1995 Jun;42(6):593-9.

PMID:
7634499
[PubMed - indexed for MEDLINE]
7.

Serum prolactin concentration at presentation of non-functioning pituitary macroadenomas.

Behan LA, O'Sullivan EP, Glynn N, Woods C, Crowley RK, Tun TK, Smith D, Thompson CJ, Agha A.

J Endocrinol Invest. 2013 Jul-Aug;36(7):508-14. doi: 10.3275/8815. Epub 2013 Feb 4.

PMID:
23385474
[PubMed - indexed for MEDLINE]
8.

High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas.

St-Jean E, Blain F, Comtois R.

Clin Endocrinol (Oxf). 1996 Mar;44(3):305-9.

PMID:
8729527
[PubMed - indexed for MEDLINE]
9.

Abnormal response of luteinizing hormone beta subunit to thyrotrophin-releasing hormone in patients with non-functioning pituitary adenoma.

Gil-del-Alamo P, Pettersson KS, Saccomanno K, Spada A, Faglia G, Beck-Peccoz P.

Clin Endocrinol (Oxf). 1994 Nov;41(5):661-6.

PMID:
7828356
[PubMed - indexed for MEDLINE]
10.

Elevated soluble epidermal growth factor receptor level in pituitary adenoma and carcinoma.

Kong YG, Ren ZY, Su CB, Wang RZ, Ma WB, Lian W.

Chin Med Sci J. 2004 Sep;19(3):199-202.

PMID:
15506648
[PubMed - indexed for MEDLINE]
11.

Glycoprotein hormone alpha-subunit secretion in prolactinomas and in non-functioning adenomas: relation with the tumour size.

Warnet A, Porsova-Dutoit I, Lahlou N, Seret-Begue D, Lajeunie E, Chanson P, Woimant F, Lot G, Guillausseau PJ, Roger M.

Clin Endocrinol (Oxf). 1994 Aug;41(2):177-84.

PMID:
7523001
[PubMed - indexed for MEDLINE]
12.

Chromogranin A as serum marker of pituitary adenomas.

Gussi IL, Young J, Baudin E, Bidart JM, Chanson P.

Clin Endocrinol (Oxf). 2003 Nov;59(5):644-8.

PMID:
14616890
[PubMed - indexed for MEDLINE]
13.

Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas.

Ferone D, Lastoria S, Colao A, Varrella P, Cerbone G, Acampa W, Merola B, Salvatore M, Lombardi G.

J Clin Endocrinol Metab. 1998 Jan;83(1):248-52.

PMID:
9435450
[PubMed - indexed for MEDLINE]
14.

Pituitary adenomas secreting large amounts of prolactin may give false low values in immunoradiometric assays. The hook effect.

Petakov MS, Damjanović SS, Nikolić-Durović MM, Dragojlović ZL, Obradović S, Gligorović MS, Simić MZ, Popović VP.

J Endocrinol Invest. 1998 Mar;21(3):184-8.

PMID:
9591215
[PubMed - indexed for MEDLINE]
15.

Serum levels of beta-subunit of chorionic gonadotropin in patients with pituitary tumors.

Gil-del-Alamo P, Saccomanno K, Lania A, Pettersson KS, Beck-Peccoz P, Spada A.

Eur J Endocrinol. 1995 Jul;133(1):33-7.

PMID:
7542981
[PubMed - indexed for MEDLINE]
16.

Basal, pulsatile, entropic, and 24-hour rhythmic features of secondary hyperprolactinemia due to functional pituitary stalk disconnection mimic tumoral (primary) hyperprolactinemia.

Veldman RG, Frölich M, Pincus SM, Veldhuis JD, Roelfsema F.

J Clin Endocrinol Metab. 2001 Apr;86(4):1562-7.

PMID:
11297584
[PubMed - indexed for MEDLINE]
17.

The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas.

Di Sarno A, Landi ML, Marzullo P, Di Somma C, Pivonello R, Cerbone G, Lombardi G, Colao A.

Clin Endocrinol (Oxf). 2000 Jul;53(1):53-60.

PMID:
10931080
[PubMed - indexed for MEDLINE]
18.

Impaired estrogen-induced negative feedback on gonadotropin secretion in patients with gonadotropin-secreting and nonfunctioning pituitary adenomas.

Lania A, Gangi E, Romoli R, Losa M, Travaglini P, Meringolo D, Ambrosi B, Faglia G, Beck-Peccoz P, Spada A.

Eur J Clin Invest. 2002 May;32(5):335-40.

PMID:
12027873
[PubMed - indexed for MEDLINE]
19.

Cabergoline: a first-choice treatment in patients with previously untreated prolactin-secreting pituitary adenoma.

Cannavò S, Curtò L, Squadrito S, Almoto B, Vieni A, Trimarchi F.

J Endocrinol Invest. 1999 May;22(5):354-9.

PMID:
10401709
[PubMed - indexed for MEDLINE]
20.

Clinical results of 24 pituitary macroadenomas with linac-based stereotactic radiosurgery.

Yoon SC, Suh TS, Jang HS, Chung SM, Kim YS, Ryu MR, Choi KH, Son HY, Kim MC, Shinn KS.

Int J Radiat Oncol Biol Phys. 1998 Jul 1;41(4):849-53.

PMID:
9652848
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk